Therefore, we realized that CD44 may not be necessary for angiogenesis under physiological conditions but is crucial for pathological angiogenesis following MI and may serve as a biomarker of early angiogenesis after AMI, leading to a positive effect on impaired cardiac function in a later stage of MI. Here, CD44 is linked to myocardial infarction.